EGFR-mutated NSCLC (Disorder)
1 clinical trials · Condition
◉ Watch EGFR-mutated NSCLC (Disorder)
| Record | Firm | Date |
|---|---|---|
| MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC (NCT03418532) | Molecular Partners AG | 2018-03-22 |
Track EGFR-mutated NSCLC (Disorder) automatically
Every clearance here is in the API, with alerts when new ones post.